Richard J Simpson
Overview
Explore the profile of Richard J Simpson including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
354
Citations
15645
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Cracchiolo M, Davis L, Matiatos A, Davini D, Husnain M, Simpson R, et al.
Cancer Chemother Pharmacol
. 2024 Jun;
94(3):361-372.
PMID: 38878208
Purpose: The purpose of this study was to analyze potential differences in antitumor efficacy and pharmacokinetics between intravenous (IV) bendamustine and a novel orally administered (PO) bendamustine agent that is...
2.
Greening D, Rai A, Simpson R
Proteomics
. 2024 Apr;
24(11):e2400128.
PMID: 38676335
No abstract available.
3.
Baker F, Smith K, Mylabathula P, Zuniga T, Diak D, Batatinha H, et al.
Cancer Res Commun
. 2024 Apr;
4(5):1253-1267.
PMID: 38592213
Significance: Exercise mobilizes effector γδ T-cells to blood via β2-adrenergic signaling which allows for generation of a potent expanded γδ T-cell product that is highly cytotoxic against hematologic malignancies.
4.
Gunning J, Gilman K, Zuniga T, Simpson R, Limesand K
PLoS One
. 2024 Mar;
19(3):e0297387.
PMID: 38470874
Head and neck cancer treatment often consists of surgical resection of the tumor followed by ionizing radiation (IR), which can damage surrounding tissues and cause adverse side effects. The underlying...
5.
Suwakulsiri W, Xu R, Rai A, Chen M, Shafiq A, Greening D, et al.
Proteomics
. 2024 Mar;
24(11):e2300058.
PMID: 38470197
Previously, we reported that human primary (SW480) and metastatic (SW620) colorectal (CRC) cells release three classes of membrane-encapsulated extracellular vesicles (EVs); midbody remnants (MBRs), exosomes (Exos), and microparticles (MPs). We...
6.
Cracchiolo M, Davis L, Matiatos A, Davini D, Husnain M, Simpson R, et al.
Res Sq
. 2024 Feb;
PMID: 38313301
Purpose: The purpose of this study was to analyze potential differences in antitumor efficacy and pharmacokinetics between intravenous (IV) bendamustine (BEN) and a novel orally administered bendamustine agent (PO) that...
7.
Fiuza-Luces C, Valenzuela P, Galvez B, Ramirez M, Lopez-Soto A, Simpson R, et al.
Nat Rev Immunol
. 2024 Feb;
24(3):229.
PMID: 38302654
No abstract available.
8.
Filioglou D, Husnain M, Khurana S, Simpson R, Katsanis E
Front Immunol
. 2023 Dec;
14:1329850.
PMID: 38077398
The most common lymphodepletion regimen used prior to infusion of chimeric antigen receptor-T cells (CAR-T) is cyclophosphamide (CY) in combination with fludarabine (Flu) (CY-FLU). While cyclophosphamide (CY) possesses lymphotoxic effects,...
9.
Nakano M, Sakamoto T, Kitano Y, Bono H, Simpson R, Tabunoki H
BMC Genomics
. 2023 Dec;
24(1):735.
PMID: 38049715
Background: The frass of several herbivorous insect species has been utilised as natural medicines in Asia; however, the metabolite makeup and pharmaceutical activities of insect frass have yet to be...
10.
Fiuza-Luces C, Valenzuela P, Galvez B, Ramirez M, Lopez-Soto A, Simpson R, et al.
Nat Rev Immunol
. 2023 Oct;
24(4):282-293.
PMID: 37794239
Regular physical activity is associated with lower cancer incidence and mortality, as well as with a lower rate of tumour recurrence. The epidemiological evidence is supported by preclinical studies in...